Related Experiment Videos
Antineutrophil cytoplasmic autoantibodies antigen specificity
1Department of Nephrology and INSERM U90, Hôpital Necker, Paris, France.
Summary
The Third International ANCA Workshop confirmed proteinase 3 (PR3) and myeloperoxidase (MPO) as major targets for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. While other ANCA specificities exist, most patients show monospecificity.
Area of Science:
- Immunology
- Autoimmunity
- Rheumatology
Background:
- Antineutrophil cytoplasmic autoantibodies (ANCA) are key diagnostic markers in systemic vasculitis.
- Previous studies suggested heterogeneity in ANCA antigenic targets.
- The Third International ANCA Workshop aimed to standardize and define ANCA specificities.
Purpose of the Study:
- To better define the antigenic specificities of ANCA.
- To confirm the predominant antigens targeted by ANCA in vasculitic patients.
- To explore the relationship between ANCA specificities and clinical conditions.
Main Methods:
- Analysis of results from the Third International ANCA Workshop.
- Comparison of amino acid and DNA sequences for antigen identification.
- Characterization of ANCA reactivity in patient sera.
Main Results:
- Proteinase 3 (PR3) and myeloperoxidase (MPO) were confirmed as the predominant ANCA antigen specificities in vasculitis patients.
- PR3 was identified as identical to AGP7, p29, and myeloblastin.
- Other ANCA specificities, including cationic antimicrobial protein (CAP57) and cathepsin G, were identified but are rare.
- Most ANCA-positive sera were monospecific for a single antigen.
- A significant proportion of granulocyte-specific antinuclear antibodies (GS-ANA) in rheumatoid arthritis and ulcerative colitis were found to be part of the ANCA family.
Conclusions:
- PR3 and MPO are the primary targets of ANCA in vasculitis.
- ANCA antigen specificity is largely monospecific, despite a variety of identified targets.
- Further research is needed to elucidate the fine specificity of GS-ANA and their role in ANCA-associated diseases.